The new Available Medicines registry contains 23 International Nonproprietary Names
for Pharmaceutical Substances (INN).
The company has also received approval from the United States Adopted Names (USAN) Council and the International Nonproprietary Names
(INN) Expert Group at the World Health Organisation (WHO) for the use of non-proprietary name darvadstrocel for Cx601.
The agency also expects that having distinguishable nonproprietary names
should help health care practitioners and patients identify different biologic drugs.
Addition of Brazilian and International Nonproprietary Names
to architecture to support more effective searching in languages other than English
57) Outside of the United States, the World Health Organization (WHO) assigns drugs' nonproprietary names
--the International Nonproprietary Names
Currently there are no nonproprietary names
(no nomenclature systems) for approved biologics that reflect the nature of the products (and active agents), what they are, with current non-proprietary names highly constrained by regulatory requirements.
Arranged alphabetically from acacia to zinc stearate, each entry is described in terms of 22 topics, among them: nonproprietary names
, synonyms, chemical name and CAS registry number, empirical formula and molecular weight and structural formula, functional category, supplications, physical appearance, pharmacopeial specifications, typical properties, stability and storage, incompatibilities, manufacture, safety, handling precautions, regulatory status, and related substances.
The RxNorm standard clinical drug vocabulary produced by the National Library of Medicine (NLM) now contains more accurate and complete connections between National Drug Codes (NDCs) and standard nonproprietary names
of medications recommended for use in electronic health records (EHRs).
Each monograph includes information on nonproprietary names
, synonyms, chemical name and Chemical Abstracts Service registry number, empirical formula and molecular weight, structural formula, functional category, applications in pharmaceutical formulation or technology, description, pharmacopoeial specifications, typical properties, stability and storage conditions, incompatibilities, method of manufacture, safety, handling precautions, regulatory status, related substances, specific and general references, and date of revision.
Finally, the Report presents a comprehensive review of International Nonproprietary Names
(INN) for Biological and Biotechnological Substances, which is likely to be of interest to all those dealing with health products.
WHOs INN Expert Group and the USAN Council approve simple, informative and unique nonproprietary names
, also known as generic names, for drugs to allow for clear communication among health professionals and to identify chemical/pharmacological relationships.